Patents by Inventor Claudio Lorck

Claudio Lorck has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7276253
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: August 11, 2006
    Date of Patent: October 2, 2007
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Publication number: 20070048380
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Application
    Filed: August 11, 2006
    Publication date: March 1, 2007
    Inventors: Gerd-Ulfert Heese, Herbert Junger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Publication number: 20050064035
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Application
    Filed: September 16, 2003
    Publication date: March 24, 2005
    Inventors: Gerd-Ulfert Heese, Herbert Junger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Patent number: 6623759
    Abstract: The invention relates to a stable medicament for oral administration which comprises (a) a core which contains an active ingredient selected from Omeprazole, Lansoprazole and Pantoprazole, together with customary pharmaceutical adjuvants, (b) an intermediate layer applied onto the core, and (c) a gastric juice-resistant outer layer. The intermediate layer in (b) is formed as a reactive layer in which a gastric juice-resistant polymer layer material partially neutralized with alkali with cation exchange capacity is present. Further, a method for the production of the stable medicament is disclosed.
    Type: Grant
    Filed: September 5, 2001
    Date of Patent: September 23, 2003
    Assignee: AstraZeneca AB
    Inventors: Gerd-Ulfert Heese, Herbert Jünger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss
  • Publication number: 20020054913
    Abstract: The invention relates to a stable medicament for oral administration which comprises
    Type: Application
    Filed: September 5, 2001
    Publication date: May 9, 2002
    Inventors: Gerd-Ulfert Heese, Herbert Junger, Arnim Laicher, Claudio Lorck, Thomas Profitlich, Gerd Weiss